Correlation Between Revelation Biosciences and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Puma Biotechnology, you can compare the effects of market volatilities on Revelation Biosciences and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Puma Biotechnology.
Diversification Opportunities for Revelation Biosciences and Puma Biotechnology
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Revelation and Puma is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Puma Biotechnology go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Puma Biotechnology
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Puma Biotechnology. In addition to that, Revelation Biosciences is 2.23 times more volatile than Puma Biotechnology. It trades about -0.08 of its total potential returns per unit of risk. Puma Biotechnology is currently generating about 0.0 per unit of volatility. If you would invest 389.00 in Puma Biotechnology on September 15, 2024 and sell it today you would lose (101.00) from holding Puma Biotechnology or give up 25.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revelation Biosciences vs. Puma Biotechnology
Performance |
| Timeline |
| Revelation Biosciences |
| Puma Biotechnology |
Revelation Biosciences and Puma Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Puma Biotechnology
The main advantage of trading using opposite Revelation Biosciences and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.| Revelation Biosciences vs. Puma Biotechnology | Revelation Biosciences vs. Iovance Biotherapeutics | Revelation Biosciences vs. Day One Biopharmaceuticals | Revelation Biosciences vs. Inozyme Pharma |
| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |